Filtering serum eye drops: does it remove key healing molecules?
NCT ID NCT07407101
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study involved 10 adults with severe dry eye disease who did not respond to standard treatments. Researchers measured levels of growth factors and vitamins in autologous serum eye drops before and after filtration, to see if filtering reduces their concentration. The goal is to help standardize how these drops are made in France.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous serum eye drops
- What this could lead to
- If successful, this could help standardize the preparation of autologous serum eye drops, potentially improving treatment consistency for severe dry eye disease.
- What could go wrong
- This is a very small, early-stage study with only 10 participants, focused on lab measurements rather than patient outcomes. Results may not translate to better symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROME (DES) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Limoges
Limoges, 87042, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fewer drops, same relief? trial tests Twice-Daily systane complete against standard Four-Times-Daily regimen
- Can a simple eye drop stop dry eye after LASIK?
- Scientists hunt for protein clues in severe dry eye treatment
- New eye drop for dry eyes enters safety testing
- Tear test: new study probes how dry eye drug alters eye proteins
- Honey eyedrops: a sweet solution for dry eyes?